Scholar Rock’s Phase 3 SMA Trial Achieves Success

October 9, 2024

Rett syndrome drug by Acadia approved by U.S. FDA

March 29, 2023

Madrigal Signs Licensing Deal with CSPC for Preclinical GLP-1 Candidate in $2 Billion Agreement

August 2, 2025

Must Read

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

April 22, 2026

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

April 21, 2026

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

April 21, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Pharma News Websites You Should Follow in 2026

How Are Life Sciences Companies Raising Capital in 2026?

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Clinical

Cerecor’s Covid-19 antibody treatment will get fast-track treatment from FDA

Editor Picks

Scholar Rock’s Phase 3 SMA Trial Achieves Success

Rett syndrome drug by Acadia approved by U.S. FDA

Madrigal Signs Licensing Deal with CSPC for Preclinical GLP-1 Candidate in $2 Billion Agreement

Must Read

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Hot Topics

About Us

Follow Us